European Organisation for Research and Treatment of Cancer (EORTC) shared on LinkedIn:
“This Pink October, meet the people moving breast cancer research forward: the EORTC Breast Cancer Group.
This Group brings together 770+ experts from across Europe and beyond, collaborating through international clinical research to improve breast cancer care.
Among its ongoing research studies are:
- TREAT ctDNA: investigating whether elacestrant prevents distant relapse in ER+/HER2- breast cancer patients with ctDNA relapse.
- APPALACHES: tests adjuvant palbociclib as an alternative to chemotherapy in elderly patients with high-risk ER+/HER2- early breast cancer.
- AURORA: a molecular screening programme for metastatic breast cancer.
- NEOLDER: exploring tailored neoadjuvant treatment approaches for older women (70+) with HER2-positive breast cancer.
Pink October 2026: Advancing breast cancer research, together.
You can also read: October Is Breast Cancer Awareness Month: Turning Awareness Into Earlier Diagnosis and Better Care.
